{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:22:26Z","timestamp":1780384946941,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA029701-01S1"],"award-info":[{"award-number":["R01AA029701-01S1"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["F32AA029288"],"award-info":[{"award-number":["F32AA029288"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["F31AA029295"],"award-info":[{"award-number":["F31AA029295"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["K24AA025704"],"award-info":[{"award-number":["K24AA025704"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R21AA029771"],"award-info":[{"award-number":["R21AA029771"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Animal models are used for preliminary testing of novel compounds for alcohol use disorder (AUD). However, it is unclear whether early efficacy in preclinical models reliably predicts efficacy in human laboratory and clinical trials. We searched the literature for medications tested for AUD in preclinical models (i.e., two-bottle choice [2-BC] and operant reinstatement), human laboratory cue-reactivity, and randomized clinical trials (RCTs). For preclinical models, we computed medication effects on 2-BC alcohol preference and consumption (k\u2009=\u200977 studies, 14 medications) as well as operant reinstatement (k\u2009=\u200918 studies, 8 medications). For human laboratory studies, we computed medication effects on alcohol cue-induced craving (k\u2009=\u200936 studies, 15 medications). For RCTs, we computed medication effects on RCT endpoints including return to any drinking and return to heavy drinking (k\u2009=\u2009139 studies, 19 medications). We used medication as the unit of analysis and applied the Williamson-York bivariate weighted least squares estimation to preserve the errors in both the independent and dependent variables. Medication effects on 2-BC alcohol preference (<jats:inline-formula>\n              <jats:alternatives>\n                <jats:tex-math>$$\\hat{\\beta }$$<\/jats:tex-math>\n                <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mover>\n                    <mml:mrow>\n                      <mml:mi>\u03b2<\/mml:mi>\n                    <\/mml:mrow>\n                    <mml:mo>\u02c6<\/mml:mo>\n                  <\/mml:mover>\n                <\/mml:math>\n              <\/jats:alternatives>\n            <\/jats:inline-formula>\u2009=\u20090.04, <jats:italic>p<\/jats:italic>\u2009=\u20090.004) and reinstatement (<jats:inline-formula>\n              <jats:alternatives>\n                <jats:tex-math>$$\\hat{\\beta }$$<\/jats:tex-math>\n                <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                  <mml:mover>\n                    <mml:mrow>\n                      <mml:mi>\u03b2<\/mml:mi>\n                    <\/mml:mrow>\n                    <mml:mo>\u02c6<\/mml:mo>\n                  <\/mml:mover>\n                <\/mml:math>\n              <\/jats:alternatives>\n            <\/jats:inline-formula>\u2009=\u20090.20, <jats:italic>p<\/jats:italic>\u2009=\u20090.05) were positively associated with medication effects on return to any drinking in human clinical trials but no associations were found on other RCT outcomes tested. Preclinical medications findings were not associated with medication effects on cue-induced craving in the human laboratory. Medication findings on 2-BC alcohol preference and operant reinstatement track medication effects on select clinical trial outcomes, specifically return to any drinking. This study provides empirical support for the association between medication effects across species and experimental models, a critical, yet untested, premise of preclinical studies in medications development.<\/jats:p>","DOI":"10.1038\/s41398-025-03473-6","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T04:33:13Z","timestamp":1753072393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Translating medication effects for alcohol use disorder across preclinical, human laboratory, and clinical trial outcomes using meta-analysis"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1158-5211","authenticated-orcid":false,"given":"Steven J.","family":"Nieto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanna","family":"Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7584-9488","authenticated-orcid":false,"given":"Lindsay R.","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wave-Ananda","family":"Baskerville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1594-7796","authenticated-orcid":false,"given":"Kaitlin R.","family":"McManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Magill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5885-7371","authenticated-orcid":false,"given":"Marcelo F.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8042-6957","authenticated-orcid":false,"given":"Howard C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5734-9444","authenticated-orcid":false,"given":"Lara A.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"3473_CR1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.31887\/DCNS.2017.19.3\/rspanagel","volume":"19","author":"R Spanagel","year":"2017","unstructured":"Spanagel R. Animal models of addiction. Dialogues Clin Neurosci. 2017;19:247\u201358.","journal-title":"Dialogues Clin Neurosci"},{"key":"3473_CR2","first-page":"5","volume":"2013","author":"SE Hyman","year":"2013","unstructured":"Hyman SE. Psychiatric drug development: diagnosing a crisis. Cerebrum. 2013;2013:5.","journal-title":"Cerebrum"},{"key":"3473_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01615-0","volume":"11","author":"SJ Nieto","year":"2021","unstructured":"Nieto SJ, Grodin EN, Aguirre CG, Izquierdo A, Ray LA. Translational opportunities in animal and human models to study alcohol use disorder. Transl Psychiatry. 2021;11:496.","journal-title":"Transl Psychiatry"},{"key":"3473_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1126\/science.91.2369.507","volume":"91","author":"CP Richter","year":"1940","unstructured":"Richter CP, Campbell KH. Alcohol taste thresholds and concentrations of solution preferred by rats. Science. 1940;91:507\u201309.","journal-title":"Science"},{"key":"3473_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/B978-0-444-62619-6.00005-7","volume":"125","author":"JC Crabbe","year":"2014","unstructured":"Crabbe JC. Use of animal models of alcohol-related behavior. Handb Clin Neurol. 2014;125:71\u201386.","journal-title":"Handb Clin Neurol"},{"key":"3473_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1369-1600.2009.00192.x","volume":"15","author":"RF Leeman","year":"2010","unstructured":"Leeman RF, Heilig M, Cunningham CL, Stephens DN, Duka T, O\u2019Malley SS. Ethanol consumption: how should we measure it? Achieving consilience between human and animal phenotypes. Addict Biol. 2010;15:109\u201324.","journal-title":"Addict Biol"},{"key":"3473_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1749-6632.2010.05895.x","volume":"1216","author":"JC Crabbe","year":"2011","unstructured":"Crabbe JC, Harris RA, Koob GF. Preclinical studies of alcohol binge drinking. Ann N Y Acad Sci. 2011;1216:24\u201340.","journal-title":"Ann N Y Acad Sci"},{"key":"3473_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0893-133X(99)00167-0","volume":"22","author":"AJ Roberts","year":"2000","unstructured":"Roberts AJ, Heyser CJ, Cole M, Griffin P, Koob GF. Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology. 2000;22:581\u201394.","journal-title":"Neuropsychopharmacology"},{"key":"3473_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.alcohol.2014.01.006","volume":"48","author":"S Carnicella","year":"2014","unstructured":"Carnicella S, Ron D, Barak S. Intermittent ethanol access schedule in rats as a preclinical model of alcohol abuse. Alcohol. 2014;48:243\u201352.","journal-title":"Alcohol"},{"key":"3473_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.15288\/jsa.1993.54.235","volume":"54","author":"PM Monti","year":"1993","unstructured":"Monti PM, Rohsenow DJ, Rubonis AV, Niaura RS, Sirota AD, Colby SM, et al. Alcohol cue reactivity: effects of detoxification and extended exposure. J Stud Alcohol. 1993;54:235\u201345.","journal-title":"J Stud Alcohol"},{"key":"3473_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1037\/0021-843X.106.2.243","volume":"106","author":"NL Cooney","year":"1997","unstructured":"Cooney NL, Litt MD, Morse PA, Bauer LO, Gaupp L. Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men. J Abnorm Psychol. 1997;106:243\u201350.","journal-title":"J Abnorm Psychol"},{"key":"3473_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.54.1.1","volume":"54","author":"U Shalev","year":"2002","unstructured":"Shalev U, Grimm JW, Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev. 2002;54:1\u201342.","journal-title":"Pharmacol Rev"},{"key":"3473_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","volume":"168","author":"Y Shaham","year":"2003","unstructured":"Shaham Y, Shalev U, Lu L, de Wit H, Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology. 2003;168:3\u201320.","journal-title":"Psychopharmacology"},{"key":"3473_CR14","doi-asserted-by":"crossref","unstructured":"Weiss F Alcohol self-administration. In: Olmstead MC, editor Animal models of drug addiction. Totowa, NJ: Humana Press; 2011. p. 133-66.","DOI":"10.1007\/978-1-60761-934-5_5"},{"key":"3473_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.brat.2016.05.008","volume":"86","author":"S Bujarski","year":"2016","unstructured":"Bujarski S, Ray LA. Experimental psychopathology paradigms for alcohol use disorders: applications for translational research. Behav Res Ther. 2016;86:11\u201322.","journal-title":"Behav Res Ther"},{"key":"3473_CR16","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41386-020-00913-3","volume":"46","author":"LA Ray","year":"2021","unstructured":"Ray LA, Du H, Green R, Roche DJO, Bujarski S. Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder. Neuropsychopharmacology. 2021;46:519\u201327.","journal-title":"Neuropsychopharmacology"},{"key":"3473_CR17","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s00213-024-06589-7","volume":"241","author":"SJ Nieto","year":"2024","unstructured":"Nieto SJ, Du H, Meredith LR, Donato S, Magill M, Ray LA. Leveraging meta-regression to test if medication effects on cue-induced craving are associated with clinical efficacy. Psychopharmacology. 2024;241:1679\u201389.","journal-title":"Psychopharmacology"},{"key":"3473_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.alcohol.2024.06.007","volume":"120","author":"S Donato","year":"2024","unstructured":"Donato S, Meredith LR, Nieto SJ, Bujarski S, Ray LA. Medication development for aud: a systematic review of clinical trial methodology. Alcohol. 2024;120:194\u2013203.","journal-title":"Alcohol"},{"key":"3473_CR19","unstructured":"The EndNote Team. EndNote. EndNote X9 ed. Philadelphia, PA: Clarivate, 2013."},{"key":"3473_CR20","first-page":"36","volume":"17","author":"Z Munn","year":"2019","unstructured":"Munn Z, Aromataris E, Tufanaru C, Stern C, Porritt K, Farrow J, et al. The development of software to support multiple systematic review types: the Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI). JBI Evid Implement. 2019;17:36\u201343.","journal-title":"JBI Evid Implement"},{"key":"3473_CR21","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1007\/s00213-023-06409-4","volume":"240","author":"LA Ray","year":"2023","unstructured":"Ray LA, Nieto SJ, Meredith LR, Burnette E, Donato S, Magill M, et al. Are medication effects on subjective response to alcohol and cue-induced craving associated? A meta regression study. Psychopharmacology. 2023;240:1921\u201330.","journal-title":"Psychopharmacology"},{"key":"3473_CR22","unstructured":"Bormann I. 2012. DigitizeIt. Version 2.0 ed. http:\/\/www.digitizeit.de\/."},{"key":"3473_CR23","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1111\/acer.15143","volume":"47","author":"LR Meredith","year":"2023","unstructured":"Meredith LR, Burnette EM, Nieto SJ, Du H, Donato S, Grodin EN, et al. Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: a systematic review and quantitative synthesis of human laboratory trial methodology. Alcohol Clin Exp Res. 2023;47:1629\u201345.","journal-title":"Alcohol Clin Exp Res"},{"key":"3473_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3102\/10769986006002107","volume":"6","author":"LV Hedges","year":"1981","unstructured":"Hedges LV. Distribution theory for Glass\u2019s estimator of effect size and related estimators. J Educ Stat. 1981;6:107\u201328.","journal-title":"J Educ Stat"},{"key":"3473_CR25","unstructured":"Hedges LV, Olkin I Statistical methods for meta-analysis. Academic press; Orlando, Florida, USA, 2014."},{"key":"3473_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36:1\u201348.","journal-title":"J Stat Softw"},{"key":"3473_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177\u201388.","journal-title":"Control Clin Trials"},{"key":"3473_CR28","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1139\/p68-523","volume":"46","author":"J Williamson","year":"1968","unstructured":"Williamson J. Least-squares fitting of a straight line. Can J Phys. 1968;46:1845\u201347.","journal-title":"Can J Phys"},{"key":"3473_CR29","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1139\/p66-090","volume":"44","author":"D York","year":"1966","unstructured":"York D. Least-squares fitting of a straight line. Can J Phys. 1966;44:1079\u201386.","journal-title":"Can J Phys"},{"key":"3473_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0012-821X(68)80059-7","volume":"5","author":"D York","year":"1968","unstructured":"York D. Least squares fitting of a straight line with correlated errors. Earth Planet Sci Lett. 1968;5:320\u201324.","journal-title":"Earth Planet Sci Lett"},{"key":"3473_CR31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1119\/1.1632486","volume":"72","author":"D York","year":"2004","unstructured":"York D, Evensen NM, Mart\u0131nez ML, De Basabe Delgado J. Unified equations for the slope, intercept, and standard errors of the best straight line. Am J Phys. 2004;72:367\u201375.","journal-title":"Am J Phys"},{"key":"3473_CR32","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/adb.12349","volume":"22","author":"MM Yardley","year":"2017","unstructured":"Yardley MM, Ray LA. Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models. Addict Biol. 2017;22:581\u2013615.","journal-title":"Addict Biol"},{"issue":"Supplement C","key":"3473_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuropharm.2017.02.004","volume":"122","author":"RL Bell","year":"2017","unstructured":"Bell RL, Hauser SR, Liang T, Sari Y, Maldonado-Devincci A, Rodd ZA. Rat animal models for screening medications to treat alcohol use disorders. Neuropharmacology. 2017;122(Supplement C):201\u201343.","journal-title":"Neuropharmacology"},{"key":"3473_CR34","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1111\/acer.13829","volume":"42","author":"LA Ray","year":"2018","unstructured":"Ray LA, Bujarski S, Roche DJO, Magill M. Overcoming the \u201cValley of Death\u201d in medications development for alcohol use disorder. Alcohol Clin Exp Res. 2018;42:1612\u201322.","journal-title":"Alcohol Clin Exp Res"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03473-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03473-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03473-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T16:03:11Z","timestamp":1757260991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03473-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3473"],"URL":"https:\/\/doi.org\/10.1038\/s41398-025-03473-6","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"250"}}